NCT06939504

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Evaluation of the Relative Bioavailability of HRS-9813 Capsule and Tablet in Healthy Subjects and the Effect of Food on the Pharmacokinetics of HRS-9813 Capsule

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a phase Ⅰ study to evaluate the relative bioavailability of HRS-9813 capsule and tablet in healthy subjects and the effect of food on the pharmacokinetics of HRS-9813 capsule.

Conditions

• Pulmonary Fibrosis

Interventions

Type	Name	Description
DRUG	HRS-9813 Capsule	HRS-9813 capsule.
DRUG	HRS-9813 Tablet	HRS-9813 tablet.

Timeline

• Start date: 2025-05-04
• Primary completion: 2025-06-03
• Completion: 2025-06-23
• First posted: 2025-04-22
• Last updated: 2025-07-08

Locations

1 site across 1 country: China